Here is the honest evidence status up front: the individual compounds have real human data Tesamorelin is an FDA-approved prescription drug (EGRIFTA) for HIV-associated lipodystrophy, and Ipamorelin has been characterized in human GH-release studies but the fixed Tesamorelin + Ipamorelin blend as sold for research has no completed human randomized controlled trial of its own
They include a sluggish metabolism, vitamin and mineral deficiencies, and even resistance to insulin
Commonly reported side effects of GLP-1 include nausea, vomiting, diarrhea, abdominal pain, and constipation
Absorbance was detected by using a microplate spectrophotometer (Bio-Rad) at 490 nm
Marissa's program is built around an actual medical relationship: full intake, baseline labs, a documented plan, dose titration based on your response, and the option to step down or pause if needed